Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.
Department of Social Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.
JAMA Netw Open. 2024 Sep 3;7(9):e2434699. doi: 10.1001/jamanetworkopen.2024.34699.
IMPORTANCE: Atherogenesis starts during childhood, making childhood and adolescence an important window of opportunity to prevent atherosclerotic cardiovascular disease later in life. OBJECTIVE: To identify early-life risk factors for preclinical atherosclerosis in adolescence. DESIGN, SETTING, AND PARTICIPANTS: This cohort study is part of the ongoing Wheezing Illness Study in Leidsche Rijn (WHISTLER) prospective birth cohort study, which includes 3005 healthy newborns born between December 2001 and December 2012 in the Leidsche Rijn area of Utrecht, the Netherlands. Eligible participants included those from the WHISTLER cohort who visited the clinic between March 2019 and October 2020 for adolescent follow-up. This study's analyses were performed in January 2024. EXPOSURES: Early-life growth was assessed at birth to 6 months, 5 years, and 12 to 16 years. Abdominal ultrasonography determined abdominal subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) depth. Blood pressure (BP) percentiles and body mass index (BMI) z scores were used. MAIN OUTCOMES AND MEASURES: Carotid ultrasonography was performed at age 12 to 16 years to assess carotid intima-media thickness (cIMT) and the distensibility coefficient (DC), established measures of preclinical atherosclerosis. Multivariable linear regression models were used to identify early-life risk factors for cIMT and DC in adolescence. RESULTS: In total, 232 adolescents (median [IQR] age, 14.9 [13.7-15.8] years; 121 female [52.2%]) were included. More postnatal weight gain (B = 12.34; 95% CI, 2.39 to 22.39), higher systolic BP at 5 years (B = 0.52; 95% CI, 0.02 to 1.01), more VAT at 5 years (B = 3.48; 95% CI, 1.55 to 5.40), and a larger change in VAT between 5 and 12 to 16 years (B = 3.13; 95% CI, 1.87 to 4.39) were associated with a higher cIMT in adolescence. A higher BMI (B = -2.70, 95% CI,-4.59 to -0.80) and VAT at 5 years (B = -0.56; 95% CI, -0.87 to -0.25), as well as a larger change in BMI between 5 and 12 to 16 years (B = -3.63; 95% CI, -5.66 to -1.60) were associated with a higher carotid stiffness in adolescence. On the contrary, a larger change in SAT between 5 and 12 to 16 years (B = 0.37; 95% CI, 0.16 to 0.58) was associated with a higher carotid DC in adolescence. CONCLUSIONS AND RELEVANCE: In this cohort study of 232 participants, early-life growth parameters, and particularly abdominal VAT development, were associated with a higher cIMT and carotid stiffness in adolescence. These findings suggest that assessment of adipose tissue development during childhood can aid characterization of lifetime risk trajectories and tailoring of cardiovascular prevention and risk management strategies.
重要性:动脉粥样硬化形成始于儿童期,因此儿童期和青春期是预防成年后动脉粥样硬化性心血管疾病的重要窗口期。 目的:确定青春期前临床动脉粥样硬化的早期生命风险因素。 设计、设置和参与者:本队列研究是正在进行的莱德克里恩(WHISTLER)前瞻性出生队列研究的一部分,该研究包括荷兰乌得勒支莱德克里恩地区 2001 年 12 月至 2012 年 12 月期间出生的 3005 名健康新生儿。符合条件的参与者包括 WHISTLER 队列中那些在 2019 年 3 月至 2020 年 10 月期间因青少年随访而就诊的人。本研究的分析于 2024 年 1 月进行。 暴露:从出生到 6 个月、5 岁和 12 至 16 岁评估早期生命生长情况。腹部超声检查确定腹部皮下脂肪组织(SAT)和内脏脂肪组织(VAT)深度。使用血压(BP)百分位数和体重指数(BMI)z 评分。 主要结果和措施:在 12 至 16 岁时进行颈动脉超声检查,以评估颈动脉内膜-中层厚度(cIMT)和弹性系数(DC),这是评估临床前动脉粥样硬化的既定指标。使用多变量线性回归模型确定青少年时期 cIMT 和 DC 的早期生命风险因素。 结果:共有 232 名青少年(中位数[IQR]年龄,14.9[13.7-15.8]岁;121 名女性[52.2%])入选。更多的出生后体重增加(B=12.34;95%CI,2.39 至 22.39)、5 岁时更高的收缩压(B=0.52;95%CI,0.02 至 1.01)、5 岁时更高的 VAT(B=3.48;95%CI,1.55 至 5.40)以及 5 至 12 至 16 岁之间 VAT 变化更大(B=3.13;95%CI,1.87 至 4.39)与青春期更高的 cIMT 相关。更高的 BMI(B=-2.70,95%CI,-4.59 至-0.80)和 5 岁时的 VAT(B=-0.56;95%CI,-0.87 至-0.25)以及 5 至 12 至 16 岁之间 BMI 的更大变化(B=-3.63;95%CI,-5.66 至-1.60)与青春期更高的颈动脉僵硬度相关。相反,5 至 12 至 16 岁之间 SAT 的更大变化(B=0.37;95%CI,0.16 至 0.58)与青春期更高的颈动脉 DC 相关。 结论和相关性:在这项针对 232 名参与者的队列研究中,早期生命生长参数,特别是腹部 VAT 发育,与青春期更高的 cIMT 和颈动脉僵硬度相关。这些发现表明,评估儿童期脂肪组织发育可以帮助确定终生风险轨迹,并为心血管预防和风险管理策略的制定提供依据。
JAMA Netw Open. 2024-9-3
J Clin Endocrinol Metab. 2013-1-2
Eur J Prev Cardiol. 2015-11
Pediatrics. 2022-12-1
Pediatrics. 2022-11-1
N Engl J Med. 2022-5-19
Front Cardiovasc Med. 2020-11-26
JACC Cardiovasc Imaging. 2021-2
Am J Physiol Regul Integr Comp Physiol. 2018-3-1
Nat Rev Cardiol. 2017-10-12